Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418477
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-05-13
Brief Title:
Daratumumab Bortezomib Cyclophosphamide and Dexamethasone Therapy for Patients with MIDD
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Organization Data
Organization:
Peking University Peoples Hospital
Class:
OTHER
Study ID:
2024PHB134-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Jin Lu MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University Peoples Hospital
Old Name:
None
Old Organization:
None